ArticleOncogene2021

Is PD-L1 a consistent biomarker for anti-PD-1 therapy? The model of balstilimab in a virally-driven tumor.

Joseph E Grossman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.